—

Sands Capital Alternatives, LLC

Q1 2026 13F Holdings

  • Location
    arlington, VA
  • Num holdings

    21

  • Value ($000)

    $421,198

  • Date Filed
    05/08/2026
  • Form type
    13F-HR
  • CIK
    0001846444
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
N
NU

NU HLDGS LTD

ORD SHS CL A
G6683N103
$93.95M
22 %

6,537,769

K
KVYO

KLAVIYO INC

COM SER A
49845K101
$71.02M
17 %

3,649,678

---

SPYGLASS PHARMA INC

COM SHS
85220G109
$64.78M
15 %

2,500,012

---

BETA BIONICS INC

COM
08659B102
$37.15M
9 %

3,708,043

I
IKT

INHIBIKASE THERAPEUTICS INC

COM NEW
45719W205
$21.87M
5 %

13,018,965

C
CPNG

COUPANG INC

CL A
22266T109
$19.11M
5 %

1,012,091

I
IOT

SAMSARA INC

COM CL A
79589L106
$17.76M
4 %

560,287

D
DASH

DOORDASH INC

CL A
25809K105
$16.7M
4 %

111,231

---

BIOAGE LABS INC

COM
09077V100
$13.75M
3 %

786,353

T
TXG

10X GENOMICS INC

CL A COM
88025U109
$10.23M
2 %

481,770

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 21